SYRS
Syros Pharmaceuticals, Inc. - Common Stock (SYRS)
$00
About Syros Pharmaceuticals, Inc. - Common Stock (SYRS)
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.31
52 Week Low
$0.00
Market cap
13,400
Dividend yield
0.00%
Volume
--
Avg. volume
34,799
P/E ratio
.00
Syros Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.31
52 Week Low
$0.00
Market cap
13,400
Dividend yield
0.00%
Volume
--
Avg. volume
34,799
P/E ratio
.00